Search 33,000+ CME courses
Back

StatPearls, LLC

  • Endometrial Neoplasms
  • Hysterectomy
  • Menorrhagia
  • Metrorrhagia
  • Progesterone

Premalignant Lesions of the Endometrium

Premalignant lesions of the endometrium are a characteristic sequence of atypical endometrial hyperplasia or intraepithelial neoplasia that may give rise to the two main types of endometrial carcinomas. Type 1 occurs in estrogen predominance and/or progesterone insufficiency state and resembles proliferative endometrium. Type 2 is the serous type of endometrial carcinoma normally seen with postmenopausal endometrial atrophy, where mutation of P53 leads to intraepithelial carcinoma and progression. Type 1, on the other hand, harbors the inactivation of PTEN and other pathways. The presenting symptoms for premalignant lesions are menorrhagia and metrorrhagia (type 1) and postmenopausal bleeding (type 2). Management of premalignant lesions includes hysterectomy (total hysterectomy, not supracervical hysterectomy). In selected younger patients wanting to have children, medical management with high-dose gestagen therapy with appropriate close histological monitoring may be done. Untreated, almost all premalignant lesions of endometrium would progress to invasive carcinoma over a period of a few years. This activity highlights the role of the interprofessional team in managing patients suffering from premalignant lesions of the endometrium.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1.5 creditsAAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left

Related courses

See all

Other providers’ courses on the same topic

More from StatPearls, LLC

See all

This provider’s courses closest to this one